Skip to main content
. 2023 Mar 30;91(1):89–98. doi: 10.1159/000530431

Table 3.

Summary of the most frequent immunophenotypic markers expressed by the neoplastic blasts based on the flow cytometry

Diagnosis CD34 (% cases) CD117 (% cases) CD7 (% cases) CD56 (% cases) HLA-DR (% cases) CD38 (% cases) Mk (% cases) CD36 (% cases)
TAM 11/11 (100) 11/11 (100) 10/11 (91) 6/11 (55) 8/11 (73) 7/8 (88) 5/10 (50) 6/11 (55)
ML-DS 22/28 (79) 24/27 (89) 20/28 (71) 14/28 (50) 13/25 (52) 8/19 (42) 17/26 (65) 10/28 (36)

Mk, megakaryocyte markers (CD41, CD61, and CD42b).